|
ThermoGenesis, GE Healthcare sign Res-Q distribution agreement |
|
Friday, 18 June 2010 |
ThermoGenesis, a supplier of products for processing and storing adult stem cells, has signed a non-exclusive distribution agreement with GE Healthcare for its Res-Q 60 BMC (Res-Q), a device used to prepare cell concentrates, including stem cells, from bone marrow. The new agreement lays foundation for extending bone marrow offering into new indications. The agreement, which excludes orthopedic indications in the US, is the fifth new distribution agreement and the second new agreement with GE Healthcare the company has completed in calendar 2010. Reportedly, in January, ThermoGenesis had signed an enhanced distribution agreement with GE Healthcare for its AXP AutoXpress (AXP) System, used to process stem cells from cord blood, in a number of regions throughout the world. Res-Q 60, introduced in mid-2009, enables preparation of cell concentrates from bone marrow aspirate at the intra-operative point of care or in a laboratory setting in a easy-to-use procedure.
|
